Displaying 1 - 7 of 7
Blood cancer research extended further with LLSC partnerships
Updated:
Beyond the scope of our research grant opportunities, LLSC is pleased to have other opportunities to partner in co-funding research with like-minded organizations.
Research
Precision medicine, chemotherapy alternatives, and zebrafish genes
Updated:
Canadian researchers exploring precision medicine with immunotherapy have received a total of $600,000 from the Leukemia and Lymphoma Society of Canada (LLSC) for pediatric blood cancer research innovation.
Partners, Pediatrics, Research
Insights from BioCanRX Summit for Cancer Immunotherapy 2023
Updated:
I just got back from the 2023 BioCanRX Summit4ci that was held in Ottawa October 1-4 and I want to share a few of the amazing highlights that have come out of the conference this year.
Partners, Research, Events
A third of blood cancer research funding to women investigators in Canada
Updated:
The Leukemia & Lymphoma Society of Canada $5 million investment includes a strong focus on an aggressive, complex form of blood cancer.
Research
Hope for People with Acute Myeloid Leukemia
Updated:
This is a preview of Shawn Omstead's story brought to you by Healthinsight.ca
Media Mentions, Research
$3 million for blood cancer research
Updated:
The Cancer Research Society (CRS) and the Leukemia and Lymphoma Society of Canada (LLSC) are jointly announcing an exceptional partnership, amounting to $3 million, dedicated to research on blood cancers.
Research
LLSC partners with BioCanRx
Updated:
A new partnership between LLSC and BioCanRx will help Canadian scientists expand their ability to conduct clinical trials of CAR T therapy, an important new treatment for some blood cancers that have not responded to other treatments.
Education, Research